Subtopic Deep Dive
Neuroimaging in Neurodegeneration with Brain Iron Accumulation
Research Guide
What is Neuroimaging in Neurodegeneration with Brain Iron Accumulation?
Neuroimaging in Neurodegeneration with Brain Iron Accumulation (NBIA) uses quantitative MRI techniques like susceptibility mapping and R2* relaxometry to detect iron deposits in basal ganglia across genetic subtypes.
NBIA encompasses progressive disorders with iron accumulation, axonal spheroids, and movement disorders (Gregory et al., 2008, 359 citations). Key neuroimaging reveals characteristic basal ganglia iron patterns distinguishing subtypes (Kruer et al., 2011, 213 citations). Recent advances apply quantitative susceptibility mapping (QSM) for precise iron quantification (Ravanfar et al., 2021, 198 citations).
Why It Matters
Quantitative susceptibility mapping enables non-invasive monitoring of iron progression in NBIA trials, supporting endpoints for therapies targeting genetic subtypes like WDR45 or ATP13A2 mutations (Haack et al., 2012, 358 citations; Schneider et al., 2010, 187 citations). These methods differentiate NBIA from mimics like hereditary spastic paraplegia, aiding diagnosis (Kruer et al., 2011, 213 citations). Iron dysregulation links to neurodegeneration mechanisms, informing metabolic interventions (Hare et al., 2013, 428 citations).
Key Research Challenges
Distinguishing NBIA Subtypes
Iron deposition patterns vary across NBIA genes like PLA2G6, WDR45, and ATP13A2, complicating radiological diagnosis (Hayflick et al., 2013, 246 citations). Conventional MRI lacks specificity for subtle differences (Kruer et al., 2011, 213 citations). QSM improves resolution but requires standardization (Ravanfar et al., 2021, 198 citations).
Quantifying Longitudinal Iron Changes
Tracking iron accumulation over time demands reproducible QSM and R2* metrics across scanners (Ravanfar et al., 2021, 198 citations). Few longitudinal NBIA studies exist, limiting progression models (Gregory et al., 2008, 359 citations). Genetic heterogeneity confounds correlations with clinical decline.
Linking Iron to Metabolic Pathology
Iron redox cycling disrupts neurotransmitter synthesis and mitochondrial function in NBIA (Hare et al., 2013, 428 citations). Neuroimaging must integrate with genetic and biochemical data for causal insights (Zhou and Tan, 2017, 208 citations). Validating imaging as therapy biomarkers remains unproven.
Essential Papers
A delicate balance: Iron metabolism and diseases of the brain
Dominic J. Hare, Scott Ayton, Ashley I. Bush et al. · 2013 · Frontiers in Aging Neuroscience · 428 citations
Iron is the most abundant transition metal within the brain, and is vital for a number of cellular processes including neurotransmitter synthesis, myelination of neurons, and mitochondrial function...
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Allison Gregory, Brenda J. Polster, Susan J. Hayflick · 2008 · Journal of Medical Genetics · 359 citations
Neurodegeneration with brain iron accumulation (NBIA) describes a group of progressive neurodegenerative disorders characterised by high brain iron and the presence of axonal spheroids, usually lim...
Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA
Tobias B. Haack, Penelope Hogarth, Michael C. Kruer et al. · 2012 · The American Journal of Human Genetics · 358 citations
Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms
Temistocle Lo Giudice, Federica Lombardi, Filippo M. Santorelli et al. · 2014 · Experimental Neurology · 336 citations
Beta-propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation
Susan J. Hayflick, Michael C. Kruer, Allison Gregory et al. · 2013 · Brain · 246 citations
Neurodegenerative disorders with high iron in the basal ganglia encompass an expanding collection of single gene disorders collectively known as neurodegeneration with brain iron accumulation. Thes...
Genetic and phenotypic characterization of complex hereditary spastic paraplegia
Eleanna Kara, Arianna Tucci, Claudia Manzoni et al. · 2016 · Brain · 218 citations
The hereditary spastic paraplegias are a heterogeneous group of degenerative disorders that are clinically classified as either pure with predominant lower limb spasticity, or complex where spastic...
Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation
Michael C. Kruer, Nathalie Boddaert, Susanne A. Schneider et al. · 2011 · American Journal of Neuroradiology · 213 citations
NBIA characterizes a class of neurodegenerative diseases that feature a prominent extrapyramidal movement disorder, intellectual deterioration, and a characteristic deposition of iron in the basal ...
Reading Guide
Foundational Papers
Start with Gregory et al. (2008, 359 citations) for NBIA definition, then Kruer et al. (2011, 213 citations) for core neuroimaging patterns, followed by Hare et al. (2013, 428 citations) for iron mechanisms.
Recent Advances
Ravanfar et al. (2021, 198 citations) for QSM systematic review; Hayflick et al. (2013, 246 citations) for BPAN subtype imaging.
Core Methods
Quantitative susceptibility mapping (QSM) inverts phase data for iron concentration; R2* relaxometry quantifies T2* decay from paramagnetic iron; applied to basal ganglia in NBIA (Ravanfar et al., 2021; Kruer et al., 2011).
How PapersFlow Helps You Research Neuroimaging in Neurodegeneration with Brain Iron Accumulation
Discover & Search
Research Agent uses citationGraph on Kruer et al. (2011, 213 citations) to map NBIA neuroimaging evolution from Gregory et al. (2008) to Ravanfar et al. (2021), then exaSearch for 'QSM NBIA longitudinal' uncovers 50+ related papers. findSimilarPapers expands to hereditary spastic paraplegia overlaps (Lo Giudice et al., 2014).
Analyze & Verify
Analysis Agent applies readPaperContent to extract QSM protocols from Ravanfar et al. (2021), then runPythonAnalysis on R2* datasets for statistical comparisons across NBIA subtypes using pandas. verifyResponse with CoVe and GRADE grading confirms iron quantification reproducibility claims against Hare et al. (2013).
Synthesize & Write
Synthesis Agent detects gaps in longitudinal QSM for ATP13A2-NBIA (Schneider et al., 2010), flagging contradictions in iron patterns. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations for 20+ NBIA papers, and latexCompile for iron deposition diagrams via exportMermaid.
Use Cases
"Analyze R2* values from NBIA QSM papers with statistics."
Research Agent → searchPapers('NBIA R2* relaxometry') → Analysis Agent → readPaperContent(Ravanfar 2021) → runPythonAnalysis(pandas groupby on susceptibility values by subtype) → CSV export of means/SDs for progression modeling.
"Draft LaTeX review on QSM in WDR45-NBIA."
Synthesis Agent → gap detection (Haack 2012 imaging gaps) → Writing Agent → latexGenerateFigure(basal ganglia iron maps) → latexSyncCitations(10 NBIA papers) → latexCompile → PDF with mermaid susceptibility timelines.
"Find code for NBIA iron quantification analysis."
Research Agent → searchPapers('NBIA QSM pipeline') → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect(QSM processing scripts) → runPythonAnalysis(test on sample R2* data).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ NBIA papers: searchPapers → citationGraph → DeepScan (7-step QSM validation with CoVe checkpoints). Theorizer generates hypotheses linking iron metabolism (Hare 2013) to NBIA progression models from Kruer 2011 imaging. DeepScan verifies subtype-specific iron patterns across Haack 2012 and Hayflick 2013.
Frequently Asked Questions
What defines Neuroimaging in NBIA?
Quantitative MRI susceptibility mapping and R2* relaxometry detect basal ganglia iron deposits distinguishing NBIA subtypes (Kruer et al., 2011, 213 citations; Ravanfar et al., 2021, 198 citations).
What are key NBIA neuroimaging methods?
QSM provides iron-specific contrast; R2* measures relaxation from iron; both outperform T2* for NBIA globus pallidus hyperintensities (Ravanfar et al., 2021, 198 citations; Kruer et al., 2011, 213 citations).
What are seminal NBIA papers?
Gregory et al. (2008, 359 citations) delineates clinical genetics; Kruer et al. (2011, 213 citations) details neuroimaging features; Ravanfar et al. (2021, 198 citations) reviews QSM applications.
What open problems exist in NBIA neuroimaging?
Standardizing multi-site QSM for trials; longitudinal iron tracking per genotype; imaging-therapy correlations (Ravanfar et al., 2021; Schneider et al., 2010).
Research Neurological diseases and metabolism with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Neuroimaging in Neurodegeneration with Brain Iron Accumulation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers